ArticleCardio-oncology (London, England)2026
Temporal trends in cardiac arrest and cancer-related mortality among adults in the United States, 1999-2023.
Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac arrest (CA) remains a major contributor to cardiovascular-related mortality in the United States. The coexistence of cancer significantly exacerbates overall disease burden. This study investigates CA and cancer-related trends and demographic disparities in adults from 1999 to 2023.
methodsThis retrospective analysis of CDC WONDER data investigates the trends in mortality associated with CA in patients with cancer. Using Joinpoint regression analysis, the study calculated age-adjusted mortality rates (AAMR) per 100,000 individuals and corresponding annual percentage changes (APC), along with 95% confidence intervals.
resultsBetween 1999 and 2023, CA and cancer–related mortality accounted for 1,503,315 deaths. With an AAPC of -2.3 (95% CI: -2.4 to -2.1, p < 0.001), the overall AAMR decreased from 37.3 in 1999 to 21.1 in 2023. Adult men had higher AAMRs than women (men: 48.4; women: 30.4) in 1999 to (men: 25.7; women: 17.8) in 2023, with decline for both sexes [men: AAPC: -2.5, p < 0.001; women: AAPC: -2.2, p < 0.001]. AAMRs varied significantly by race, for NH Black individuals (57.6 to 28.1), NH American Indians (22.1 to 15.5), Hispanics (44.6 to 24.7) and NH Whites (34.4 to 19.5) from 1999 to 2023 respectively. The greatest decline in AAMR was observed in middle-aged adults (AAPC: -2.3, p < 0.001). Regionally, the highest decline was seen in South region (AAPC: -3.3, p < 0.001). AAMRs varied by state, from 5.2 in West Virginia to 55.3 in California during 2023.
conclusionThis study reveals significant demographic and geographic disparities in CA and cancer-related mortality in U.S. adults from 1999 to 2023, with a disproportionately high burden observed among older adults, males, and NH Black individuals. These findings underscore the urgent need for targeted, equity-driven public health strategies for high-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.